[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349666-105":59,"doc-detail-349666-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-utilities-of-platelet-derived-growth-factor-signaling-in-breast-cancer","Clinical utilities of platelet-derived growth factor signaling in breast cancer","","Platelet-derived growth factors (PDGFs) and their receptors PDGFRα/β are central to breast cancer progression and metastasis. This review synthesizes evidence on PDGF ligand and receptor expression patterns, oncogenic roles, prognostic value, and druggability, emphasizing small-molecule inhibition. PDGF-PDGFR signaling contributes to epithelial-to-mesenchymal transition, cancer stem cell maintenance, desmoplasia, angiogenesis, and immune modulation, with distinct functions across the four PDGF ligands.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-utilities-of-platelet-derived-growth-factor-signaling-in-breast-cancer/349666/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-utilities-of-platelet-derived-growth-factor-signaling-in-breast-cancer/349666.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What roles does PDGF-PDGFR signaling play in breast cancer progression?","Question",{"text":112,"@type":113},"PDGF-PDGFR signaling contributes to epithelial-to-mesenchymal transition, cancer stem cell maintenance, desmoplasia, angiogenesis, and immune modulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do different PDGF ligands (PDGFA–PDGFD) relate to breast cancer biology?",{"text":117,"@type":113},"PDGFA and PDGFB are implicated in breast cancer-associated brain metastasis, PDGFC supports fibroblast activation, and PDGFD may activate epithelial-to-mesenchymal transition.",{"name":119,"@type":110,"acceptedAnswer":120},"Which PDGF-PDGFR targeting therapeutic strategies are highlighted?",{"text":121,"@type":113},"The review evaluates approaches targeting the PDGF-PDGFR axis, including neutralizing antibodies, aptamers, and small-molecule inhibitors, noting preclinical promise but limited clinical success to date.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349666,1790421051,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":29,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Pharmacol Res. Author manuscript; available in PMC 2026 September 16. |\n| --- | --- |\n\nPublished in final edited form as:  \nPharmacol Res. 2026 September ; 231: 108372. doi:10.1016/j.phrs.2026.108372 .  \nClinical utilities of platelet-derived growth factor signaling in breast cancer  \nJesse J. Reardona,b, Alexis A. Mossinga,b, Rebecca L. Packarda,b, Sajita Shaha,b, Gina M. Sizemorea,b,*  \naThe Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA b Department of Radiation Oncology, The Ohio State University, Columbus, Ohio 43210, USA  \nAbstract  \nPlatelet-derived growth factors (PDGFs) and their cognate receptors (PDGFRα/β) play critical roles in breast cancer progression and metastasis. This review summarizes current evidence of PDGF ligand and receptor expression patterns, oncogenic functions, prognostic significance and therapeutic targetability, with a specific focus on small molecule inhibition. PDGF-PDGFR signaling is known to contribute to epithelial to mesenchymal transition, cancer stem cell maintenance, desmoplasia, angiogenesis, and immune modulation. Additionally, the four PDGF ligands have distinct oncogenic functions. PDGFA and PDGFB have been implicated in breast cancer associated brain metastasis, while PDGFC has been shown to play a crucial role in fibroblast activation. PDGFD, while less studied, may activate epithelial to mesenchymal transition in breast cancer. High expression of PDGFA, PDGFB, PDGFC, and stromal PDGFRβ correlate with poor patient survival, highlighting their potential as candidate biomarkers. We specifically focus on evaluating current therapeutic strategies which target the PDGF-PDGFR axis, including neutralizing antibodies, aptamers, and small molecule inhibitors, which show preclinical promise but limited clinical success in breast cancer to date. We discuss future research directions with emphasis on identifying selective inhibitors, utilizing PDGF-PDGFR signaling components for patient stratification, and combination with immunotherapies.  \nThis is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \n*Correspondence to: Department of Radiation Oncology, The James Comprehensive Cancer Center, The Ohio State University, 646C Tzagournis Medical Research Facility, 420 W. 12th Avenue, Columbus, OH 43210, [USA. gina.sizemore@osumc.edu](USA. gina.sizemore@osumc.edu) (G.M. Sizemore) .  \nDeclaration of generative AI and AI-assisted technologies in the manuscript preparation process  \nDuring the preparation of this work, the authors used Microsoft Copilot to improve readability, grammar, and to assist in drafting revisions based on published literature. After using this tool, the authors reviewed, edited, and verified all content and take full responsibility for the content of this publication.  \nCRediT authorship contribution statement  \nJesse J. Reardon: Writing – review & editing, Writing – original draft, Visualization, Investigation, Conceptualization. Alexis A. Mossing: Writing – review & editing, Writing – original draft, Visualization, Investigation, Conceptualization. Rebecca L. Packard:  \nWriting – review & editing, Writing – original draft, Visualization, Investigation, Conceptualization. Sajita Shah: Writing – review & editing, Writing – original draft, Visualization, Investigation, Conceptualization. Gina M. Sizemore: Writing – review & editing, Writing – original draft, Supervision, Conceptualization, Resources.  \nDeclaration of Competing Interest All authors have nothing to declare.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nReardon et al. Page 2  \nKeywords  \nBreast cancer; PDGF; PDGFR; Prognosis; Small molecule inhibition; Therapeutics  \n1. Introduction  \n1.1. Breast cancer heterogeneity and continuing cli","cbCaikIAT3RRXJwL","https://ap.wps.com/l/cbCaikIAT3RRXJwL","pdf",894799,51,"English","# Introduction\n## Breast cancer heterogeneity and continuing clinical challenges\n# Keywords","[{\"question\":\"What roles does PDGF-PDGFR signaling play in breast cancer progression?\",\"answer\":\"PDGF-PDGFR signaling contributes to epithelial-to-mesenchymal transition, cancer stem cell maintenance, desmoplasia, angiogenesis, and immune modulation.\"},{\"question\":\"How do different PDGF ligands (PDGFA–PDGFD) relate to breast cancer biology?\",\"answer\":\"PDGFA and PDGFB are implicated in breast cancer-associated brain metastasis, PDGFC supports fibroblast activation, and PDGFD may activate epithelial-to-mesenchymal transition.\"},{\"question\":\"Which PDGF-PDGFR targeting therapeutic strategies are highlighted?\",\"answer\":\"The review evaluates approaches targeting the PDGF-PDGFR axis, including neutralizing antibodies, aptamers, and small-molecule inhibitors, noting preclinical promise but limited clinical success to date.\"}]","Clinical utilities of platelet-derived growth factor signaling in breast cancer | PDF",1790084901,129,[147,151,155,159,163,167],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d292406a7f7cebebff8156aaf71298b4.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2ffd23865aa7f4412d765469564b00a.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2cb273aca08c30edec2cd8b1691e22a.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7565c14a39f6005ab653f256d992eba7.webp",980,1268,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c34a69eb008f95729e7b1868261331cb.webp",979,1267,{"page_no":29,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8892d50ced317f7289d1a077d72e542a.webp",978,1265]